Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways

https://doi.org/10.1016/j.taap.2021.115697Get rights and content

Highlights

  • TAD and BG reduced STZ-induced hippocampal insult and improved cognitive function.

  • TAD and BG ameliorated the crosstalk between cGMP/PKG and Wnt/β-catenin cassettes.

  • TAD and BG halted neuroinflammation.

  • TAD and BG reduced Aβ deposition and Tau hyperphosphorylation.

Abstract

Sporadic Alzheimer's disease (SAD) is a slowly progressive neurodegenerative disorder. This study aimed to investigate neuroprotective potential of tadalafil (TAD) and bergapten (BG) in SAD-induced cognitive impairment in mice. SAD was induced by single injection of streptozotocin (STZ; 3 mg/kg, ICV). STZ resulted in AD-like pathologies including Aβ deposition, tau aggregation, impaired insulin and Wnt/β-catenin signaling, as well as autophagic dysfunction and neuroinflammation. Administration of TAD or BG at doses of 20 and 25 mg/kg, respectively, for 21 consecutive days attenuated STZ-induced hippocampal insult, preserved neuronal integrity, and improved cognitive function in the Morris water maze and object recognition tests paralleled by reduction in Aβ expression by 79 and 89% and tau hyperphosphorylation by 60 and 61%, respectively. TAD and BG also enhanced protein expression of pAkt, pGSK-3β, beclin-1 and methylated protein phosphatase 2A (PP2A) and gene expression of cyclin D1, while raised BDNF immunoreactivity. Furthermore, TAD and BG boosted hippocampal levels of cGMP, PKG, Wnt3a, and AMPK and reduced expression of β-catenin and mTOR by 74% and 51%, respectively. TAD and BG also halted neuroinflammation by reducing IL-23 and IL-27 levels, as well as protein expression of NF-κB by 62% & 61%, respectively. In conclusion, this study offers novel insights on the neuroprotective effects of TAD or BG in the management of SAD as evidenced by improved cognitive function and histological architecture. This could be attributed to modulation of the crosstalk among PI3K/Akt/GSK-3β, PP2A, mTOR/autophagy, cGMP/PKG, and Wnt/β-catenin signaling cascades and mitigation of neuroinflammation.

Introduction

Sporadic Alzheimer's disease (SAD) is the most dominant form of dementia (Sabogal-Guáqueta et al., 2020). Its pathology is multifactorial and involves the accumulation of hyperphosphorylated tau proteins (pTau) with subsequent formation of neurofibrillary tangles (NFTs), deposition of amyloid beta (Aβ) plaques and neurodegeneration (Takahashi et al., 2017). Activation of phosphatidylinositol 3-kinase (PI3K) through growth factors including insulin, promotes cell survival and synaptic plasticity (Kamat et al., 2016). PI3K inhibits the downstream kinase, glycogen kinase-3β (GSK-3β) with subsequent reduction in pTau and Aβ levels (Kamat et al., 2016). GSK-3β is also thought to mediate neuroinflammation through the positive regulation of tumor necrosis factor-α (TNFα) and nuclear factor kappa B (NF-κB) (Najem et al., 2014).

Several upstream signals such as, insulin, PI3K/protein kinase-B (Akt), 5-adenosine monophosphate-activated protein kinase (AMPK), GSK-3β and protein phosphatase 2A (PP2A) can interact with the mammalian target of rapamycin (mTOR) (Querfurth and Lee, 2021) to induce hyperphosphorylation of Tau and generation of Aβ plaques. Previous studies have shown that mTOR hyperactivation can minimize autophagy and contribute directly to Tau hyperphosphorylation and aggregation (Kou et al., 2019; Mueed et al., 2018). Moreover, the levels of inflammatory mediators are correlated with the expression of the key autophagy regulators namely; mTOR and Beclin1 (Uddin et al., 2018). In addition, severe inflammation is directly linked to disrupted autophagic process in the microglia (Houtman et al., 2019).

Another important pathway implicated in the development of SAD is the canonical Wingless-related integration site (Wnt)/β-catenin (Tapia-Rojas and Inestrosa, 2018). Accumulation of Aβ stimulates the activation of Dickkopf-1 (Dkk1), the Wnt pathway inhibitor, and promotes the degradation of cytosolic β-catenin by GSK-3β, thus inhibiting its nuclear translocation, which is crucial for neuronal survival, neurogenesis and synaptic plasticity (Jia et al., 2019). As well, reduced Wnt signaling contributes to Tau hyperphosphorylation and promotes the processing of the amyloid precursor protein (APP) with increased production of Aβ through reduction of PI3K/Akt signaling (Palomer et al., 2019). Moreover, Wnt/β-catenin shutdown is associated with neuroinflammation and increased transcription of proinflammatory genes with the activation of the microglia and astrocytes (Vallée et al., 2017). Hence, modulation of the crosstalk between neuroinflammation, autophagy, impaired insulin and Wnt/β-catenin signaling can offer new approaches to treat SAD.

Coumarins, a group of naturally occurring secondary metabolites, were found to lower blood glucose levels and increase insulin sensitivity by enhancing glucose uptake through activation of the PI3K and AMPK signaling in vitro (Jang et al., 2020). The furanocoumarin, bergapten (BG; 5-methoxypsoralen) found in a variety of medicinal plants, has been demonstrated to have antidepressant (Budzynska et al., 2016), anti-oxidant (Kowalczyk et al., 2020), and anti-inflammatory effects (Adakudugu et al., 2020). Administration of BG was further found to significantly inhibit proinflammatory cytokines (Singh et al., 2019).

Phosphodiesterase 5-inhibitors (PDE5-Is) such as tadalafil (TAD) were reported to alleviate cognitive deficits by reducing neuroinflammation and Aβ deposition (França et al., 2019; García-barroso et al., 2013; Zhang et al., 2013). Cyclic nucleotides including cyclic guanosine monophosphate (cGMP) play important role in neuroplasticity and memory formation (Argyrousi et al., 2020). Several studies showed that PDE5-Is regulate the transcription of the brain-derived neurotrophic factor (BDNF) (Cuadrado-Tejedor et al., 2011; Rosa and Fahnestock, 2015).

Accordingly, the current study aimed at investigating the possible neuroprotective potential of BG or TAD in a mouse model of SAD with a focus on the effects of PI3K/Akt, cGMP/protein kinase G (PKG) and Wnt/β-catenin signaling, as well as autophagy that all lead to initiation and perpetuation of neuroinflammation on AD hallmarks namely, Tau pathology, amyloidosis and associated cognitive deficits.

Section snippets

Animals

This study involved 8-weeks old male Swiss Albino mice (20–30 g). Animals were purchased from the breeding colony of the National Institute of Research (Giza, Egypt). Mice were kept under standardized laboratory conditions with free access to food and water. They were exposed to a 12-h light/dark cycle and controlled temperature (25 ± 5 °C). Before performing the experimental trials, the animals were allowed an adaptation period of 2 weeks. To minimize variability owing to circadian rhythm,

Effect of tadalafil or bergapten on the Morris water maze task

During the 4-day memory acquisition trial, the latency to find the hidden platform, MEL, progressively declined in all mice except for the STZ ones that showed a profound deterioration in their cognitive function as evidenced by the elevation of MEL by nearly 275% (F2.865 = 6.38), 304% (F5.14 = 16.08) and 402% (F 0.307 = 46.55) in the second, third and fourth training days, respectively as compared to the sham-control group (Fig. 1a). The prolonged latency for the STZ-induced SAD animals was

Discussion

This study provides new insights on the neuroprotective potential of the PDE5-I, TAD and the furanocoumarin, BG in AD-related cognitive, biochemical, and histological insults. Valuable assets of TAD or BG could be summarized as follows: (i) improvement of insulin signaling and neuronal survival by boosting pAkt, pGSK-3β, and mePP2A protein expression, as well as cGMP and PKG contents, while halting Tau hyperphosphorylation; (ii) refurbishment of the canonical Wnt/β-catenin signaling by

Conclusion

The present study accentuates the neuroprotective potential of the PDE5I, TAD, and the furanocoumarin, BG in an AD-like pathology as evidenced by the improved cognitive function and histological profile. The neuroprotective powers of TAD and BG could be ascribed to the modulation of the crosstalk among PI3K/Akt/GSK-3β, PP2A, mTOR/autophagy, cGMP/PKG, and Wnt/β-catenin pathways with diminution of neuroinflammation. This work provides a robust impetus into the likelihood of incorporating TAD or

Credit author statement

NS, SM, and MS generated the goal of research and performed the study design, methodology, creation of the experimental model and statistical analysis. JK & BB performed the isolation and identification of bergapten and contributed to writing the manuscript. NS, SM, and MS wrote the original draft of the manuscript. All authors read, revised and approved the final manuscript.

Declaration of Competing Interest

No conflict of interest is claimed by the authors. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Acknowledgment

The authors are grateful to Dr. Ahmed Othman (Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Egypt) for carrying out the histopathological examinations.

References (68)

  • E.A. Adakudugu et al.

    Protective effect of bergapten in acetic acid-induced colitis in rats

    Heliyon

    (2020)
  • M. Antunes et al.

    The novel object recognition memory: neurobiology, test procedure, and its modifications

    Cogn. Process.

    (2012)
  • E.K. Argyrousi et al.

    Role of cyclic nucleotides and their downstream signaling cascades in memory function: being at the right time at the right spot

    Neurosci. Biobehav. Rev.

    (2020)
  • S.K. Bose et al.

    Effect of bergapten from Heracleum nepalense root on production of proinflammatory cytokines

    Nat. Prod. Res.

    (2011)
  • B. Budzynska et al.

    In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone

    Psychopharmacology

    (2016)
  • C. Crescioli et al.

    Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells

    J. Endocrinol. Invest.

    (2013)
  • M. Cuadrado-Tejedor et al.

    Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer’s disease

    Br. J. Pharmacol.

    (2011)
  • M.P. Cunha et al.

    Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation

    Purinergic Signal

    (2015)
  • C. Gao et al.

    Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3 β pathway in streptozotocin-induced Alzheimer rat model

    Brain Pathol.

    (2014)
  • A. García-Osta et al.

    Phosphodiesterases as therapeutic targets for Alzheimer’s disease

    ACS Chem. Neurosci.

    (2012)
  • F. Hadi et al.

    Wnt signalling pathway and tau phosphorylation: a comprehensive study on known connections 1–9

    Cell Biochem. Funct.

    (2020)
  • S. Haider et al.

    Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress

    PLoS One

    (2020)
  • M.O. Hindam et al.

    Xanthotoxin and umbelliferone attenuate cognitive dysfunction in a streptozotocin-induced rat model of sporadic Alzheimer’s disease: the role of JAK2/STAT3 and Nrf2/HO-1 signalling pathway modulation

    Phyther. Res

    (2020)
  • J. Houtman et al.

    Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3

    EMBO J.

    (2019)
  • C.F. Janssen et al.

    Comparison of Atipamezole with Yohimbine for antagonism of Xylazine in mice anesthetized with Ketamine & Xylazine

    J. Am. Assoc. Lab. Anim. Sci.

    (2017)
  • L. Jia et al.

    Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

    Mol. Brain

    (2019)
  • Y. Jiao et al.

    Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer’s disease

    Neuropharmacology

    (2016)
  • P.K. Kamat et al.

    Streptozotocin Intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic intervention for treatment of sporadic Alzheimer’s disease (sAD)-like pathology

    Mol. Neurobiol.

    (2016)
  • S. Karakaya et al.

    Umbelliferone isolated from Zosima absinthifolia roots partially restored erectile dysfunction in streptozotocin-induced diabetic rats

    Med. Chem. Res.

    (2019)
  • I.G. Ko et al.

    Tadalafil improves short-term memory by suppressing ischemia-induced apoptosis of hippocampal neuronal cells in gerbils

    Pharmacol. Biochem. Behav.

    (2009)
  • X. Kou et al.

    Physical activity alleviates cognitive dysfunction of Alzheimer’s disease through regulating the mTOR signaling pathway

    Int. J. Mol. Sci.

    (2019)
  • J. Kowalczyk et al.

    Bergapten improves scopolamine-induced memory impairment in mice via cholinergic and Antioxidative mechanisms

    Front. Neurosci.

    (2020)
  • M. Kumar et al.

    Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer’ s disease: involvement of PI3-kinase, eNOS and NFκB

    Behav. Brain Res.

    (2018)
  • M. Leger et al.

    Object recognition test in mice

    Nat. Protoc.

    (2013)
  • Cited by (19)

    View all citing articles on Scopus
    View full text